Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy

Condition:   Allergy, Peanut Interventions:   Drug: ligelizumab;   Drug: Placebo Sponsor:   Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials